Why the study?
Does right ventricular dysfunction (RVD) assessment predict short-term death in patients with acute pulmonary embolism at low risk based on clinical models?
Does right ventricular dysfunction (RVD) assessment predict short-term death in patients with acute pulmonary embolism at low risk based on clinical models?
Assessment of right ventricular dysfunction via imaging or biomarkers improves risk stratification in clinically low-risk acute PE patients, aiding in the identification of candidates for outpatient management.
Supports RVD assessment to guide outpatient decisions in low-risk acute PE; confirms short-term mortality link across modalities.
RVD assessed by echocardiography, computed tomography, or elevated BNP/NT-proBNP levels and increased troponin are associated with short-term death in patients with acute PE at low risk based on clinical models. RVD assessment, mainly by BNP/NT-proBNP or echocardiography, should be considered to improve identification of low-risk patients that may be candidates for outpatient management or short hospital stay.
No takes yet. Share an insight, caveat, or question.
Becattini et al. (2021) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: